X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-01-03 | BCYC | Thompson Travis Alvin | Chief Accounting Officer | S - Sale+OE | $17.50 | -604 | 23,375 | -3% | -$10,570 | |||||
D | 2024-01-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale+OE | $17.50 | -2,640 | 70,593 | -4% | -$46,200 | |||||
D | 2024-01-03 | BCYC | Crockett Nigel | Chief Business Officer | S - Sale+OE | $17.50 | -2,643 | 48,716 | -5% | -$46,253 | |||||
D | 2024-01-03 | BCYC | Milnes Alistair | COO | S - Sale+OE | $17.50 | -2,643 | 73,196 | -3% | -$46,253 | |||||
D | 2024-01-03 | BCYC | Skynner Michael | CTO | S - Sale+OE | $17.50 | -2,643 | 95,839 | -3% | -$46,253 | |||||
D | 2024-01-03 | BCYC | Lee Kevin | CEO | S - Sale+OE | $17.50 | -8,703 | 390,428 | -2% | -$152,303 | |||||
2023-10-03 | BCYC | Thompson Travis Alvin | Chief Accounting Officer | S - Sale | $20.00 | -54 | 7,979 | -1% | -$1,080 | ||||||
2023-10-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale | $20.00 | -272 | 45,233 | -1% | -$5,440 | ||||||
2023-10-03 | BCYC | Crockett Nigel | Chief Business Officer | S - Sale | $20.00 | -442 | 29,359 | -1% | -$8,840 | ||||||
2023-10-03 | BCYC | Milnes Alistair | COO | S - Sale | $20.00 | -442 | 36,839 | -1% | -$8,840 | ||||||
2023-10-03 | BCYC | Lee Kevin | CEO | S - Sale | $20.00 | -1,470 | 322,131 | 0% | -$29,400 | ||||||
2023-10-03 | BCYC | Skynner Michael | CTO | S - Sale | $20.00 | -442 | 70,482 | -1% | -$8,840 | ||||||
2023-07-03 | BCYC | Thompson Travis Alvin | Chief Accounting Officer | S - Sale | $25.10 | -61 | 8,033 | -1% | -$1,531 | ||||||
2023-07-03 | BCYC | Skynner Michael | CTO | S - Sale | $25.10 | -451 | 70,924 | -1% | -$11,320 | ||||||
2023-07-03 | BCYC | Milnes Alistair | COO | S - Sale | $25.10 | -451 | 37,281 | -1% | -$11,320 | ||||||
2023-07-03 | BCYC | Lee Kevin | CEO | S - Sale | $25.10 | -1,498 | 323,601 | 0% | -$37,600 | ||||||
2023-07-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale | $25.10 | -336 | 45,505 | -1% | -$8,434 | ||||||
2023-07-03 | BCYC | Crockett Nigel | Chief Business Officer | S - Sale | $25.10 | -451 | 29,801 | -1% | -$11,320 | ||||||
2023-04-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale | $21.11 | -319 | 45,841 | -1% | -$6,734 | ||||||
2023-04-03 | BCYC | Skynner Michael | CTO | S - Sale | $21.11 | -447 | 71,375 | -1% | -$9,436 | ||||||
2023-04-03 | BCYC | Milnes Alistair | COO | S - Sale | $21.11 | -447 | 37,732 | -1% | -$9,436 | ||||||
2023-04-03 | BCYC | Kalowski Lee | Pres, CFO | S - Sale | $21.11 | -376 | 30,309 | -1% | -$7,937 | ||||||
2023-04-03 | BCYC | Crockett Nigel | Chief Business Officer | S - Sale | $21.11 | -447 | 30,252 | -1% | -$9,436 | ||||||
2023-04-03 | BCYC | Lee Kevin | CEO | S - Sale | $21.11 | -1,486 | 325,099 | 0% | -$31,369 | ||||||
D | 2023-01-03 | BCYC | Crockett Nigel | Chief Business Officer | S - Sale+OE | $29.06 | -1,801 | 30,699 | -6% | -$52,337 | |||||
D | 2023-01-03 | BCYC | Milnes Alistair | COO | S - Sale+OE | $29.06 | -1,801 | 38,179 | -5% | -$52,337 | |||||
D | 2023-01-03 | BCYC | Smethurst Dominic | Chief Medical Officer | S - Sale+OE | $29.06 | -1,801 | 36,699 | -5% | -$52,337 | |||||
D | 2023-01-03 | BCYC | Skynner Michael | CTO | S - Sale+OE | $29.06 | -1,801 | 71,822 | -2% | -$52,337 | |||||
D | 2023-01-03 | BCYC | Keen Nicholas | Chief Scientific Officer | S - Sale+OE | $29.06 | -1,817 | 46,160 | -4% | -$52,802 | |||||
D | 2023-01-03 | BCYC | Kalowski Lee | Pres, CFO | S - Sale+OE | $29.06 | -1,815 | 30,685 | -6% | -$52,744 | |||||
D | 2023-01-03 | BCYC | Lee Kevin | CEO | S - Sale+OE | $29.06 | -6,000 | 326,585 | -2% | -$174,360 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |